Across the recent three months, 4 analysts have shared their insights on Bain Capital Specialty (NYSE:BCSF), expressing a variety of opinions spanning from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 2 | 2 | 0 | 0 |
| Last 30D | 0 | 1 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 0 | 1 | 0 | 0 | 0 |
Analysts have recently evaluated Bain Capital Specialty and provided 12-month price targets. The average target is $14.5, accompanied by a high estimate of $16.00 and a low estimate of $13.00. Highlighting a 4.92% decrease, the current average has fallen from the previous average price target of $15.25.
Exploring Analyst Ratings: An In-Depth Overview
In examining recent analyst actions, we gain insights into how financial experts perceive Bain Capital Specialty. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Paul Johnson | Keefe, Bruyette & Woods | Lowers | Outperform | $15.00 | $16.00 |
| Finian O'Shea | Wells Fargo | Lowers | Equal-Weight | $13.00 | $14.00 |
| Finian O'Shea | Wells Fargo | Lowers | Equal-Weight | $14.00 | $15.00 |
| Paul Johnson | Keefe, Bruyette & Woods | Maintains | Outperform | $16.00 | $16.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Bain Capital Specialty. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Bain Capital Specialty compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for Bain Capital Specialty's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
For valuable insights into Bain Capital Specialty's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Bain Capital Specialty analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
All You Need to Know About Bain Capital Specialty
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.
Bain Capital Specialty: Financial Performance Dissected
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Negative Revenue Trend: Examining Bain Capital Specialty's financials over 3M reveals challenges. As of 30 September, 2025, the company experienced a decline of approximately -40.55% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Bain Capital Specialty's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 83.63% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 1.65%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Bain Capital Specialty's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.68%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Bain Capital Specialty's debt-to-equity ratio stands notably higher than the industry average, reaching 1.33. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Analyst Ratings: Simplified
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
- No comments yet. Be the first to comment!